May 9, 20234BIO Capital Participates in $130M Funding of New Gene and Cell Manufacturing Specialist Ascend
Dec 1, 2022SparingVision’s lead asset SPVN06 clears IND application in the US for retinitis pigmentosa
Sep 21, 20224BIO Capital Portfolio Company Carisma Therapeutics and Sesen Bio Announce Merger Agreement